γ-tocopherol supplementation inhibits protein nitration and ascorbate oxidation in rats with inflammation

Free Radical Biology and Medicine

Volumn 33, Issue 11, 2002, Pages 1534-1542

  Jiang, Qing ^a,b   Lykkesfeldt, Jens ^a   Shigenaga, Mark K ^a   Shigeno, Eric T ^a   Christen, Stephan ^a,c   Ames, Bruce N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Childrens Hospital   (United States)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Tocopherol; Tocopherol; Ascorbate oxidation; Free radicals; Inflammation; Nitration; Vitamin C; Vitamin E

Indexed keywords

3 NITROTYROSINE; ALPHA TOCOPHEROL; ASCORBIC ACID; DEHYDROASCORBIC ACID; GAMMA TOCOPHEROL; PROTEIN; ZYMOSAN; 3-NITROTYROSINE; DRUG DERIVATIVE; NITROGEN; OXYGEN; TYROSINE;

ACUTE DISEASE; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIET; DIET SUPPLEMENTATION; IN VIVO STUDY; INFLAMMATION; KIDNEY; LIVER LEVEL; MALE; NITRATION; NONHUMAN; OXIDATION; PERITONITIS; PRIORITY JOURNAL; RAT; REDUCTION; STARVATION; TISSUE LEVEL; VITAMIN BLOOD LEVEL; ANIMAL; DRUG EFFECT; FISCHER 344 RAT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; TISSUE DISTRIBUTION;

ANIMALIA;

ALPHA-TOCOPHEROL; ANIMALS; ASCORBIC ACID; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GAMMA-TOCOPHEROL; INFLAMMATION; KIDNEY; MALE; NITROGEN; OXYGEN; PROTEINS; RATS; RATS, INBRED F344; TISSUE DISTRIBUTION; TYROSINE; VITAMIN E; ZYMOSAN;

EID: 0036889813     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(02)01091-2     Document Type: Article

References (53)

1. Ames B.N., Shigenaga M.K., Hagen T.M. Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. USA. 90:1993;7915-7922.
2. Christen S., Hagen T.M., Shigenaga M.K., Ames B.N. Chronic inflammation, mutation, and cancer. Parsonnet J., Microbes and malignancy: infection as a cause of human cancers. 1999;35-88 Oxford University Press, New York/Oxford.
3. McLaughlin P.J., Weihrauch J.L. Vitamin E content of foods. J. Am. Diet Assoc. 75:1979;647-665.
4. Lehmann J., Martin H.L., Lashley E.L., Marshall M.W., Judd J.T. Vitamin E in foods from high and low linoleic acid diets. J. Am. Diet. Assoc. 86:1986;1208-1216.
5. Behrens W.A., Madre R. Alpha- and gamma tocopherol concentrations in human serum. J. Am. Coll. Nutr. 5:1986;91-96.
6. Traber M.G., Kayden H.J. Preferential incorporation of α-tocopherol vs γ-tocopherol in human lipoproteins. Am. J. Clin. Nutr. 49:1989;517-526.
7. Traber M.G., Rudel L.L., Burton G.W., Hughes L., Ingold K.U., Kayden H.J. Nascent VLDL from liver perfusions of cynomolgus monkeys are preferentially enriched in RRR- compared with SRR-alpha-tocopherol studies using deuterated tocopherols . J. Lipid Res. 31:1990;687-694.
8. Traber M.G., Burton G.W., Hughes L., Ingold K.U., Hidaka H., Malloy M., Kane J., Hyams J., Kayden H.J. Discrimination between forms of vitamin E by humans with and without genetic abnormalities of lipoprotein metabolism. J. Lipid Res. 33:1992;1171-1182.
9. Jiang Q., Christen S., Shigenaga M.K., Ames B.N. Gamma-tocopherol, the major form of vitamin E in the US diet, deserves more attention. Am. J. Clin. Nutr. 74:2001;714-722.
10. Cooney R.V., Franke A.A., Harwood P.J., Hatch-Pigott V., Custer L.J., Mordan L.J. γ-Tocopherol detoxification of nitrogen dioxide superiority to α-tocopherol . Proc. Natl. Acad. Sci. USA. 90:1993;1771-1775.
11. Christen S., Woodall A.A., Shigenaga M.K., Southwell-Keely P.T., Duncan M.W., Ames B.N. gamma-tocopherol traps mutagenic electrophiles such as NO(X) and complements alpha-tocopherol physiological implications . Proc. Natl. Acad. Sci. USA. 94:1997;3217-3222.
12. 2 and their formation in rat insulinoma (RINm5F) cells. Free Radic. Biol. Med. 19:1995;259-269.
13. Hoglen N.C., Waller S.C., Sipes I.G., Liebler D.C. Reactions of peroxynitrite with gamma-tocopherol. Chem. Res. Toxicol. 10:1997;401-407.
14. Williamson K.S., Prasad Gabbita S., Mou S., West M., Pye Q.N., Markesbery W.R., Cooney R.V., Grammas P., Reimann-Philipp U., Floyd R.A., Hensley K. The nitration product 5-Nitro-gamma-tocopherol is increased in the Alzheimer brain. Nitric Oxide. 6:2002;221-227.
15. Singh R.J., Goss S.P., Joseph J., Kalyanaraman B. Nitration of gamma-tocopherol and oxidation of alpha-tocopherol by copper-zinc superoxide dismutase/H2O2/NO2- role of nitrogen dioxide free radical . Proc. Natl. Acad. Sci. USA. 95:1998;12912-12917.
16. Shigenaga M.K., Lee H.H., Blount B.C., Christen S., Shigeno E.T., Yip H., Ames B.N. Inflammation and NO(X)-induced nitration assay for 3-nitrotyrosine by HPLC with electrochemical detection . Proc. Natl. Acad. Sci. USA. 94:1997;3211-3216.
17. Christen S., Jiang Q., Shigenaga M.K., Ames B.N. Analysis of plasma tocopherols, α-, γ-, and 5-nitro-γ- in rats with inflammation by HPLC-coulometric detection. J. Lipid Res. 2002;. in press.
18. Sattler W., Mohr D., Stocker R. Rapid isolation of lipoproteins and assessment of their peroxidation by high-performance liquid chromatography postcolumn chemiluminescence. Methods Enzymol. 233:1993;469-489.
19. Lykkesfeldt J., Loft S., Poulsen H.E. Determination of ascorbic acid and dehydroascorbic acid in plasma by high-performance liquid chromatography with coulometric detection - are they reliable biomarkers of oxidative stress? Anal. Biochem. 229:1995;329-335.
20. Shigenaga M.K. Quantitation of protein-bound 3-nitrotyrosine by high-performance liquid chromatography with electrochemical detection. Methods Enzymol. 301:1999;27-40.
21. Lykkesfeldt J., Hagen T.M., Vinarsky V., Ames B.N. Age-associated decline in ascorbic acid concentration, recycling, and biosynthesis in rat hepatocytes - reversal with (R)-alpha-lipoic acid supplementation. FASEB J. 12:1998;1183-1189.
22. Shayevitz J.R., Miller C., Johnson K.J., Rodriguez J.L. Multiple organ dysfunction syndrome end organ and systemic inflammatory response in a mouse model of nonseptic origin . Shock. 4:1995;389-396.
23. Deitch E.A., Specian R.D., Grisham M.B., Berg R.D. Zymosan-induced bacterial translocation a study of mechanisms . Crit. Care Med. 20:1992;782-788.
24. Rao T.S., Currie J.L., Shaffer A.F., Isakson P.C. In vivo characterization of zymosan-induced mouse peritoneal inflammation. J. Pharmacol. Exp. Ther. 269:1994;917-925.
25. Cuzzocrea S., Zingarelli B., Sautebin L., Rizzo A., Crisafulli C., Campo G.M., Costantino G., Calapai G., Nava F., Di Rosa M., Caputi A.P. Multiple organ failure following zymosan-induced peritonitis is mediated by nitric oxide. Shock. 8:1997;268-275.
26. Cuzzocrea S., Zingarelli B., Costantino G., Sottile A., Teti D., Caputi A.P. Protective effect of poly(ADP-ribose) synthetase inhibition on multiple organ failure after zymosan-induced peritonitis in the rat. Crit. Care Med. 27:1999;1517-1523.
27. Demling R., Ikegami K., Picard L., Lalonde C. Administration of large doses of vitamin C does not decrease oxidant-induced lung lipid peroxidation caused by bacterial-independent acute peritonitis. Inflammation. 18:1994;499-510.
28. Ikegami K., Lalonde C., Young Y.K., Picard L., Demling R. Comparison of plasma reduced glutathione and oxidized glutathione with lung and liver tissue oxidant and antioxidant activity during acute inflammation. Shock. 1:1994;307-312.
29. Leeuwenburgh C., Hardy M.M., Hazen S.L., Wagner P., Oh-ishi S., Steinbrecher U.P., Heinecke J.W. Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima. J. Biol. Chem. 272:1997;1433-1436.
30. Kaur H., Halliwell B. Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Lett. 350:1994;9-12.
31. Bagasra O., Michaels F.H., Zheng Y.M., Bobroski L.E., Spitsin S.V., Fu Z.F., Tawadros R., Koprowski H. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc. Natl. Acad. Sci. USA. 92:1995;12041-12045.
32. van der Vliet A., Eiserich J.P., Halliwell B., Cross C.E. Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite. A potential additional mechanism of nitric oxide-dependent toxicity. J. Biol. Chem. 272:1997;7617-7625.
33. Jiang Q., Hurst J.K. Relative chlorinating, nitrating, and oxidizing capabilities of neutrophils determined with phagocytosable probes. J. Biol. Chem. 272:1997;32767-32772.
34. Eiserich J.P., Hristova M., Cross C.E., Jones A.D., Freeman B.A., Halliwell B., van der Vliet A. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature. 391:1998;393-397.
35. MacMillan-Crow L.A., Crow J.P., Kerby J.D., Beckman J.S., Thompson J.A. Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proc. Natl. Acad. Sci. USA. 93:1996;11853-11858.
36. Macmillan-Crow L.A., Cruthirds D.L. Invited review manganese superoxide dismutase in disease . Free Radic. Res. 34:2001;325-336.
37. Goss S.P., Hogg N., Kalyanaraman B. The effect of alpha-tocopherol on the nitration of gamma-tocopherol by peroxynitrite. Arch. Biochem. Biophys. 363:1999;333-340.
38. Morton L.W., Ward N.C., Croft K.D., Puddey I.B. Evidence for the nitration of gamma-tocopherol in vivo 5-nitro-gamma- tocopherol is elevated in the plasma of subjects with coronary heart disease . Biochem. J. 364:2002;625-628.
39. Li D., Saldeen T., Romeo F., Mehta J.L. Relative effects of alpha- and gamma-tocopherol on low-density lipoprotein oxidation and superoxide dismutase and nitric oxide synthase activity and protein expression in rats. J. Cardiovasc. Pharmacol. Ther. 4:1999;219-226.
40. Saldeen T., Li D., Mehta J.L. Differential effects of alpha- and gamma-tocopherol on low-density lipoprotein oxidation, superoxide activity, platelet aggregation and arterial thrombogenesis. J. Am. Coll. Cardiol. 34:1999;1208-1215.
41. Jiang Q., Elson-Schwab I., Courtemanche C., Ames B.N. Gamma-tocopherol and its major metabolite, in contrast to alpha-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells. Proc. Natl. Acad. Sci. USA. 97:2000;11494-11499.
42. Jiang Q., Ames B.N. In vivo anti-inflammatory effect of gamma-tocopherol. Free Radic. Biol. Med. 31:2001;123S.
43. Murray E.D. Jr., Wechter W.J., Kantoci D., Wang W.H., Pham T., Quiggle D.D., Gibson K.M., Leipold D., Anner B.M. Endogenous natriuretic factors 7 biospecificity of a natriuretic gamma- tocopherol metabolite LLU-alpha . J. Pharmacol. Exp. Ther. 282:1997;657-662.
44. Wechter W.J., Kantoci D., Murray E.D. Jr., D'Amico D.C., Jung M.E., Wang W.H. A new endogenous natriuretic factor LLU-α Proc. Natl. Acad. Sci. USA. 93:1996;6002-6007.
45. Lykkesfeldt J., Christen S., Wallock L.M., Chang H.H., Jacob R.A., Ames B.N. Ascorbate is depleted by smoking and repleted by moderate supplementation a study in male smokers and nonsmokers with matched dietary antioxidant intakes . Am. J. Clin. Nutr. 71:2000;530-536.
46. Parker R.S., Sontag T.J., Swanson J.E. Cytochrome P4503A-dependent metabolism of tocopherols and inhibition by sesamin. [in process citation] Biochem. Biophys. Res. Commun. 277:2000;531-534.
47. Shedlofsky S.I., Israel B.C., McClain C.J., Hill D.B., Blouin R.A. Endotoxin administration to humans inhibits hepatic cytochrome P450- mediated drug metabolism. J. Clin. Invest. 94:1994;2209-2214.
48. Swanson J.E., Ben R.N., Burton G.W., Parker R.S. Urinary excretion of 2,7, 8-trimethyl-2-(beta-carboxyethyl)-6-hydroxychroman is a major route of elimination of gamma-tocopherol in humans. J. Lipid Res. 40:1999;665-671.
49. Food and Nutrition Board, Institute of Medicine . Dietary reference intakes for vitamin C, vitamin E, selenium and carotenoids. 2000;186-283 National Academy Press, Washington, DC.
50. Ohrvall M., Sundlof G., Vessby B. Gamma, but not alpha, tocopherol levels in serum are reduced in coronary heart disease patients. J. Int. Med. 239:1996;111-117.
51. Kristenson M., Zieden B., Kucinskiene Z., Elinder L.S., Bergdahl B., Elwing B., Abaravicius A., Razinkoviene L., Calkauskas H., Olsson A.G. Antioxidant state and mortality from coronary heart disease in Lithuanian and Swedish men concomitant cross sectional study of men aged 50 . BMJ. 314:1997;629-633.
52. Kushi L.H., Folsom A.R., Prineas R.J., Mink P.J., Wu Y., Bostick R.M. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N. Engl. J. Med. 334:1996;1156-1162.
53. Sabate J. Nut consumption, vegetarian diets, ischemic heart disease risk, and all-cause mortality evidence from epidemiologic studies . Am. J. Clin. Nutr. 70:1999;500S-503S.